Theme: “Promising Growth Towards Cardiac Research ”

HEART 2023

HEART 2023

Conferenceseries with the support from its organizing committee members feels colossal to announce its most awaited physical event “5th Euro Cardiology Congress, scheduled on November 23-24, 2023 with the theme of “Promising Growth Towards Cardiac Research ” to address recent advancements and transformations in Cardiac researches and development. Bearing the short name "Heart 2023", this global Euro Cardiology congress would like to sincerely appreciate the presence of outstanding participants from all over the world with an enthusiastic environment in Amsterdam, Netherlands. This conference will cover up two days scientific keynote sessions, special sessions, poster presentation, networking and discussions

Abstract Submission

Abstracts should be prepared within 250 to 300 words and the submission procedure is online. The deadline for this submission is 23rd October 2023. An abstract is a summary of your research, which must include the author details, methodologies used in the research, observations & future aspects. Participants can choose their type of presentation while submitting the abstract, i.e. Oral/ Poster presentation.

                                                                              Submit Now

                                                                    Early bird registration deadline:

The early bird dates for the upcoming 5th Euro Cardiology Congress” is going to be closed on before January 23. We request to each and every participants for early registration to get an early confirmation. For group participation and packages, reach us at "".

Heart 2023 reunites the old and new faces in cardiac research in order to scale up many dedicated brains in research and the utilization of the works in businesses by driving cardiologist, medical directors, cardiac specialists, cardiac surgeons, cardiology care nurses, and scholars from all over the world to share their thoughts and to feature their accomplishments, offering the opportunity to learn about the unexpected researches, talks about interventional systems.

About conference:

Heart 2023 reunites the old and new faces in cardiac research to scale up many dedicated brains in research and the utilization of the works in businesses by driving cardiologist, medical directors, cardiac specialists, cardiac surgeons, cardiology care nurses, and scholars from around the world to share their thoughts and to feature their accomplishments, offering the opportunity to learn about the unexpected researches, talks about interventional systems.

The early bird registration for "HEART 2023" is now open for all the delegates, speakers and groups with affordable packages including both registration and accommodation. Other than the packages, participants can only register for this conference with the suitable options mentioned in the registration page.

  • Cardiologists
  • Medical Directors
  • Cardiac Surgeons
  • Cardio-thoracic Surgeons
  • Cardiac Nurses
  • Cardiology Associations and Societies
  • Business Professionals
  • Medical colleges and universities
  • Manufacturing Medical Devices and Companies
  • Healthcare Professionals
  • Clinical Research Scientists
  • Cardiology and heart science
  • Medical Students

Global Networking and Discussions:

Conference series is delighted to announce its “5th Euro Cardiology Congress” (HEART 2023), scheduled on November 23-24, 2023 Amsterdam, Netherlands, to build a networking community among cardiologist, cardiac surgeons, cardiac specialists, medical directors, professors, academicians and students from different countries and continents with different research prospective and thoughts.

Meet your topic matter specialists. Subject Matter Experts will guide you through the latest research and development. They assist you with research inquiries, content, determining objectives, and ensuring that your research is scientifically acceptable.

Workshops and interactive sessions allow participants to learn and discuss ideas. Workshops and interactive sessions entail considerable engagement between presenters and delegate around a topic or hands-on practice. These interactive meetings could take the form of a panel, a staged dialogue, or a debate, all of which include significant involvement with the participants. As a result, a variety of sessions, keynote lectures, symposiums, workshops, and poster presentations will provide you with the opportunity to share and present research to colleagues from all over the world. 

Track 1: Cardiac and Cardiovascular Research

It provides a place for scientists, researchers, and recognized professionals working in surgical and medical cardiovascular treatments to communicate knowledge. Mainly dealing with heart disorders, cardiovascular medicine, echocardiography, cardiac electrophysiology, Neuro cardiology. Recent studies have linked rheumatoid arthritis to micro vascular endothelial dysfunction, which is likely to be a major cause of an elevated risk of cardiovascular disease in patients.

The reason of Micro vascular endothelial dysfunction, which is employed as a predictive marker, determines the early determination of cardiovascular events in rheumatoid arthritis. The analytic equipment is used to assess suspected severe aortic problems, which can help to avoid surgery. Misdiagnosis, over testing, and other related issues. The analytic instrument is used for the assessment of suspected severe aortic illnesses, which can help to avoid misdiagnosis, over testing, and other related issues while diagnosing and treating patients with severe aortic disorders.

Track 2: Cardiac Nursing

A heart nurse is a nursing professional who works with patients who are affected by various heart ailments and the cardiovascular system. Under the supervision of a cardiologist, cardiovascular medical attendants assist in the treatment of illnesses such as congestive heart failure, unstable angina, myocardial infarction, cardiomyopathy, coronary artery disease, and cardiac dysrhythmia.

The majority of cardiovascular clinical nurse specialists (CNSs) work in hospitals. They care for seriously ill patients as well as those recovering from cardiovascular procedures such as bypass angioplasty or pacemaker surgery. Cardiovascular medical attendants may also be able to help patients recover at home. These medical caregivers deal with children and adults of all ages, despite the fact that heart disease has a significant impact on the elderly.

Track 03: Cardiac Surgery

Heart surgery, often known as cardiovascular surgery, is a medical treatment done on the heart or major vessels by cardiovascular specialists or surgeons. It also includes heart transplant surgery. Thoracic surgery, sometimes known as "cardiothoracic surgery," is concerned with the careful treatment of organs inside the thorax (the chest), the treatment of the lungs and lungs disorders, and the treatment of heart diseases (coronary disease).

Cardiovascular surgery, which includes the heart and major vessels, and general thoracic surgery, which includes the lungs, throat, and thymus, are separate surgical specialties in many countries, with the exceptions of the United States, Australia, New Zealand, and some EU countries, such as the United Kingdom and Portugal. To perform CABG, open-heart surgery may be required.

Track 04: Cardiac- Oncology

Cardio-oncology is another term to describe the efforts to prevent or treat patients with a tumor who are facing heart issues caused by cancer medicines. Although numerous malignancy patients also have conditions associated with Chronic obstructive pulmonary disease (COPD), other infections or chronic kidney disease (CKD), the descent of heart disease in these patients has led to the development of this new field.

Cardio-oncology is a rapidly growing discipline aiming at reducing the effects of cardiovascular illnesses and mortality in cancer survivors. To achieve this goal, patients are screened and profiled, and their cardio toxicity risk is monitored and analyzed before and after chemotherapy to look for early signs or indications of heart disease.

Track 05: Cardio Metabolic Health- Diabetes, Obesity & Metabolism

The true risk factors must be considered: cigarette smoking, elevated pulse, abnormal serum lipids and lipoproteins, and hyperglycemia, as well as the inclining risk factors: excess body weight and stomach heftiness, inactivity, and a family history of Cardiovascular illnesses (CVD).

High glucose levels in the blood can indicate a link between diabetes and coronary artery disease. It has frequently been stated that diabetes is not the problem, but rather excessive blood glucose levels. High glucose levels generate further problems because the illness destroys all of the vital organs. High hyperglycemia harms and damages veins of all shapes and sizes.

If you are overweight, a decent and balanced diet plan with minimal calories on a regular basis will lower your glucose levels and reduce your need for medications. Overabundance gut fat around your abdomen, even if you are not overweight, can increase your risk of developing heart disease.

Track 06: Cardiovascular Disease and Nutrition

The biggest cardiovascular illnesses affecting the world are mostly atherosclerosis and hypertension, both of which are greatly influenced by high calorie consumption. Numerous dietary risk factors contribute to these diseases in various ecological and ethnic settings. Coronary illnesses, stroke, hypertension, and rheumatic coronary diseases are all examples of cardiovascular diseases (CVD).

The most frequent type of cardiac disease is atherosclerotic vascular disease. CVD is the most generally recognized cause of death in many nations. CVD is caused by atherosclerosis, which is the dynamic deposition of plaque (greasy deposits) on vessel walls.

Cardiovascular diseases include coronary heart disease, stroke, heart failure, and other issues affecting the heart and veins. It is strongly linked to other chronic illnesses, such as renal disease, diabetes, and dementia. Irritation and endothelial dysfunction are the most basic pathophysiological types, followed by atherosclerosis and thrombosis

Track 07: Cardiovascular Pharmacology and Pharmacotherapy

Heart and cardiovascular disorders are the leading causes of hospitalization and death in the United States and around the world. Because of the vast potential market for these treatments, the pharmaceutical industry has prioritized the development of new therapeutic agents for cardiac disorders. A portion of these newer drugs are occasionally used in the practice of cardiovascular anesthesiology. This article examines the current developments in cardiovascular solutions connected with act of heart anesthetic cardiovascular pharmacology, focusing on the impact of diverse types of drugs on cardiovascular system regulation. It will include both cutting-edge drugs and recent advancements in understanding of more established treatments.

Some of the significant research in cardiac pharmacology: Development of novel anti-inflammatory drugs for atherosclerosis; Ion channel reconstitution studies; Endothelial-vascular smooth muscle signaling; inotropic mechanisms; Development of novel anti-ischemic agents; Cellular mechanisms of pace making and arrhythmogenesis; Pathway biology of the cardiovascular system; drug-induced cardio toxicity mechanism.

Track 08: Clinical and Experimental Cardiology

Cardiology is a branch of medicine that deals with heart problems and disease states, which can range from natural defects to acquired heart diseases, with typical examples include coronary heart disease (CHD) and congestive heart disease. Inherent heart illnesses, coronary passage dysfunction, heart disorders, valvular coronary diseases, and electrophysiology are all treated in this field.

The heart functions as a pump, pushing blood to an individual's organs, tissues, and cells. Blood conveys oxygen and supplements to every cell and empties the carbon dioxide and waste substances secreted by those cells. Blood from all regions of the body is returned to the heart. This circulatory system circulates blood throughout the body via venules and veins.

Track 9: Current Research in Cardiology

Advances in pharmacological and medical indicate that if coronary heart disease (CHD) is detected early, it can be efficiently treated to raise the survival rate. It's more likely to accomplish effective therapy if the condition is diagnosed at its early stages.

Many research centres have recently focused on the early detection of CHD with the end objective of preventing or reversing disease spread. Advances in research have included the use of heart scanning for the early detection of coronary heart disease and cardiovascular disease.

caused in diabetics, development of nuclear Cardiology technologies for determining the aetiology of heart ailments drug research evaluation and assessment of drugs used in heart illness, identification of novel biological markers to predict the existence of heart disease An examination of ethnic and socioeconomic disparities in heart disease and the dangers associated with it.

Track 11: Heart Disease: Diagnosis and Testing

Diagnostic tests are performed to distinguish between healthy and harmful cardiac problems. A regular medical checkup will also be used to assess physical condition.

An electrocardiogram, or ECG, is the principal test that detects and records the electrical activity of the heart. It is a painless test that can detect indicators of cardiac damage as well as previous or ongoing heart attacks.

Echocardiograms (ultrasound heart exams) can also determine how well the heart and valves are operating. Stress testing, Cardiac CT scan, MRI, Coronary angiography, Myocardial Biopsy, Chest x-ray, and blood tests are among the tests available.

TRACK- 12: Resuscitation and Emergency Infusions

Resuscitation is the process of restoring a patient's physiological abnormalities, such as absence of breathing or heartbeat. It is a crucial component of emergency medicine, trauma surgery, and critical care medicine. Examples include mouth-to-mouth resuscitation and cardiopulmonary resuscitation. CPR procedures;

  • High-Frequency Chest Compressions.
  • Open-Chest CPR.
  • Interposed Abdominal Compression-CPR
  • Cough CPR
  • Prone CPR
  • Precordial Thump
  • Percussion Pacing

Emergency infusions: Direct injection into the bone marrow during an emergency creates a non-collapsible entry point into the systemic venous system. When intravenous access is not possible, this approach allows for the administration of fluids and drugs.

Infusion Drugs & Types of Infusions:

  • Antibiotics
  • Biologics
  • Chemotherapy
  • Fluids
  • Heart pumps medication
  • Hemophilia factor therapy
  • Intravenous gamma globulin (IVIG)
  • Pain management

Track 13: Heart Failure and Cardiomyopathies

Congestive heart disease, often known as heart failure, is the result of the heart muscle's inability to pump blood. A weak heart or stiff heart will result from some illnesses, such as hypertension or coronary supply route sickness, which limit the amount of blood vessels the heart has and prevent the heart from filling and pumping efficiently. Your health can be improved by making lifestyle changes including exercising, managing your blood pressure, cutting back on salt in your diet, and getting more fit.

The most often acknowledged cause of heart failure is coronary artery disease (CAD), which is characterized by significant problems brought on by the narrowing of the arteries that supply the heart with blood and oxygen. The following conditions increase the risk of treating heart failure: The inability to get enough blood to the body accurately describes heart disappointment.

Track 14: Heart Devices

A heart device is used to maintain a constant cadence in the heartbeat. A few different types of gadgets are available. A heart device is necessary for someone who has heart failure with decreased ejection fraction (HF-rEF) in order to treat related problems. These irregularities are brought on by problems with the electrical system of the heart, which signal the heart to contract and pump blood throughout the body.

The creation of pacemakers, implantable cardioverter defibrillators, or ICDs, and implanted heart rhythm monitors known as loop recorders that either help the heart's electrical system work normally or assess heart rhythm is a result of technological advancement.

Track 15: Pediatric and Neonatal Cardiology

The cardiac disorders in infants, children, and adolescents are the focus of the cardiology subspecialty known as paediatric cardiology. Pediatric cardiology care in Dubai has advanced greatly over the past few years, enabling a large number of children to live today. Children with "Congenital coronary diseases," such as spaces between the heart chambers, valve problems, and unusual veins, are diagnosed, treated, and monitored by paediatric cardiologists. Children with "Arrhythmias," or irregular heart rhythms brought on by the electrical system that regulates the heartbeat, are also monitored by paediatric cardiologists. Pediatricians who specialize in basic medical care collaborate closely with paediatric cardiologists to provide streamlined, thorough treatment.

Track 16: Stem Cell Research and Regeneration on Cardiology

Since more than 150 years ago, heart regeneration has been hotly debated and subject to much research. The heart has been injured, sliced, closed up, coagulated, solidified, filled with poisons, infected, and infarcted in the pursuit of this investigation, looking at species ranging from marine spineless invertebrates to horses. The heart is one of the body's least regenerative organs, therefore if there is a regenerative response, it is comparable to those seen in many other distinct tissues, such as the liver, skeletal muscle, lung, gut, bladder, bone, or skin. For the majority of examiners, the real question is whether there is no recovery (naturally difficult to prove) or recovery at low rates (hard to identify, however conceivable with delicate methodologies).

Cardiovascular recovery is a broad endeavour that hopes to mend irreparably damaged heart tissue with science and technology, mostly through the use of free-cell and stem cell therapies. Reparative devices have been developed to restore damaged and injured heart tissue while harnessing the body's natural ability to heal. Researchers are identifying regeneration arrangements that can be re-established, recharge and utilize patients' own reparative limit. 

Track 17: Women and Heart Disease

Cardiovascular disease is especially prevalent among women, accounting for one out of every three deaths each year, or around one female per minute. Furthermore, these realities are only scratching the surface. There are a few misconceptions concerning coronary heart disease (CHD) in women that may be placing oneself at risk.

All women are at risk of developing coronary artery disease. If women are aware of the risks and side effects associated with them, adopting a heart-healthy diet and exercising can protect them from heart disease. The older a woman gets, the more likely she is to have CHD. These can occur during sleep, begin as a result of physical activity, or be triggered by mental stress. In other situations, coronary sickness may go unnoticed and undiagnosed until people experience symptoms or side effects of a heart attack, heart failure, arrhythmia, or stroke.

Track 18: Case reports on Cardiology

Case reports add significant value to the collection of medical information by providing new diseases, diagnostic tools, treatment techniques, restorative methodologies, and adverse or beneficial effects of drugs. The demonstration of recording, examining with colleagues, and publishing clinical perspectives as case reports remains fundamental to the solution and patient care.

The development of Nuclear Cardiology for the recognition of coronary sickness, as well as the use of heart scanning in the early assessment of coronary illness in diabetics are examples of ongoing research. Drug development and evaluation of medications used in CHD, Identifying biomarkers that predict the existence of cardiovascular illnesses, An examination of socioeconomic and ethnic disparities in the risk of heart disease.

Heart 2023 is the best platform for all recognized/ under- recognized scholastics in the field of Cardiology, Health specialists, analysts, educational scientists, industry researchers, scientists to exchange about research and developments in grounds of cardiology. The main focus of this meeting is to invigorate and globalize new thoughts and researches for treatment and to determine the current market for proceeding towards future of cardiovascular medicines, operational devices, and diagnostics, with an accentuation on new technology that will be advantageous in the field of Cardiology. The significance of coronary heart disease (CHD) hazard elements may vary amongst people and Communities and by sex and age. Shockingly CHD is still found to be the main cause of death, which implies that there, must be no eased up in our endeavors to wipe out this disease. Countries from the Middle East bear a heavy burden from Cardiovascular and coronary heart disease which has become the leading cause of death in the UAE, accounting for over two-thirds of all deaths, including most racial and ethnic gatherings in Dubai, UAE, and also in the United States, including African Americans.

Regional Market Analysis:

Cardiovascular medicines are specialized in the treatment of diseases related to circulatory diseases, blood clumps, stroke, coronary artery infection, arrhythmias, high cholesterol, and heart failure. Due to increasing aging population and higher rate of unhealthy life style, the market demand for cardiovascular medicines have been estimated to increase to 2.4% till 2026.

One of the huge markets for these cardiovascular medicines is North America, followed by Europe, Asia-pacific and rest of the world. United states have always been a major market for many medicines developed so far. More than 80% of the cardiovascular medicine market has been captured by the North America and European countries. Based on the types of medicines used for these cardiovascular diseases, drug markets have been categorized like anti-hypertensive, anti-coagulants, antiarrhythmic etc. Anti-hypertensive drugs are taking on the markets as compared to the other cardiovascular medicines due to its use in both cardiac and hypertensive disorders.

Societies Associated with Cardiology:

  • European Society of Cardiology
  • European Atherosclerosis Society
  • Austrian Society of Cardiology
  • German Cardiac Society
  • Italian Federation of Cardiology
  • Spanish Society of Cardiology
  • Japanese Circulation Society
  • Japanese Society of Pediatric Cardiology
  • The Japanese Heart Failure Society
  • Asian Pacific Society of Cardiology
  • The Japanese Society for Cardiovascular Surgery
  • Japanese Society of Echocardiography
  • Japanese Heart Rhythm Society
  • Korean Society of Cardiology
  • Korean Society of Interventional Cardiology
  • Korean Society of Echocardiography

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 23-24, 2023
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View